Amazon hires a new cardiologist to its healthcare division

By Catherine Sturman
Social media has taken the world by storm. Senior leadership figures, such as Elon Musk and even President Trump regularly post updates through platform...

Social media has taken the world by storm. Senior leadership figures, such as Elon Musk and even President Trump regularly post updates through platforms such as Twitter, and now another popular healthcare figure through this digital tool.

Well-known, admired cardiologist Maulik Majmudar has revealed he is set to join Amazon in an undisclosed role, with the aim to “make a truly meaningful impact on the health and wellbeing of hundreds of millions of individuals throughout the world,” he said through Twitter.

Within previous roles as Cardiologist and Associate Director at Massachusetts General Hospital, as well as lecturing and exceptional training at the esteemed Harvard Medical School, Northwestern Memorial Hospital, amongst others, Majmudar is passionate about embracing new technologies which will help transform the industry for the future.

See also

With this in mind, Majmudar has also worked as a medical adviser at Biofourmis, which has been described as “the world’s most sophisticated HIPAA compliant personalised health analytics platform based on human physiology which uses digital mHealth devices and bio-sensors to capture important clinical information towards building a precise predictive analytics engine.”

Navigating through the ongoing complexities within healthcare, from complex regulations to data protection, Amazon has hired a number of high profile figures to its health team, such as Taha Kass-Hout, former FDA Chief Health Information Officer and healthcare leader Dr Atul Gawande.

Exploring areas such as pharmacy wholesale distribution, acquiring companies such as PillPack and Xealth, the development of new medical devices and use of AI to compete against rivals such as Walgreens, as well as launch its own healthcare clinics for employees.

It’s partnership with Berkshire Hathaway and JP Morgan Chase will also further its goal to reduce ongoing escalating healthcare costs across the US, with Dr Gawande leading this venture.

Share

Featured Articles

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Itai Hayut, CEO of healthtech company Scopio Labs, on how AI & digitalisation help in the detection of blood related cancers, anaemia & allergies

2023 predictions with Harshit Jain, global CEO of Doceree

Harshit Jain, founder & global CEO of IT service Doceree, offers his 2023 predictions for the healthcare industry on affordability, marketing & telehealth

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19

World Mental Health Day: how parents can help stop bullying

Digital Healthcare

The Taiwan Excellence Award Winners on new technologies

Medical Devices & Pharma